Identification of TIM-3 as a Leukemic Stem Cell Surface Molecule in Primary Acute Myeloid Leukemia

Publisher： Karger

E-ISSN： 1423-0232|89|1|28-32

ISSN： 0030-2414

Source： Oncology, Vol.89, Iss.1, 2015-0, pp. : 28-32

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Surface Molecular Signature of Leukemic Cells Is Associated with NPM1 Mutations and FLT3-ITD in Patients with de novo Acute Myeloid Leukemia

By  

Acta Haematologica, Vol. 131, Iss. 3, 2013-10 ,pp. : 148-152

Karger

Access to resources Recommend Favorite

Sorafenib treatment following hematopoietic stem cell transplant in pediatric FLT3/ITD acute myeloid leukemia

By  

PEDIATRIC BLOOD & CANCER (ELECTRONIC), Vol. 62, Iss. 6, 2015-06 ,pp. : 1048-1054

John Wiley & Sons Inc

Access to resources Recommend Favorite

Allogeneic hematopoietic stem cell transplantation could improve survival of cytogenetically normal adult acute myeloid leukemia patients with DNMT3A mutations

By  

AMERICAN JOURNAL OF HEMATOLOGY, Vol. 90, Iss. 11, 2015-11 ,pp. : 992-997

John Wiley & Sons Inc

Access to resources Recommend Favorite

Successful allogeneic hematopoietic stem cell transplantation for acute myeloid leukemia during respiratory failure and invasive mechanical ventilation

By Boehm Alexandra  

Wiener klinische Wochenschrift, Vol. 123, Iss. 11-12, 2011-06 ,pp. : 354-358

Springer Publishing Company

Access to resources Recommend Favorite

Clinical impact of colonization with multidrug‐resistant organisms on outcome after allogeneic stem cell transplantation in patients with acute myeloid leukemia

By  

CANCER, Vol. 124, Iss. 2, 2018-01 ,pp. : 286-296

John Wiley & Sons Inc

Access to resources Recommend Favorite